Ullevål Sykehusapotek

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever, Björn Dahlöf, Neil R Poulter et al. · The Lancet · 2003 · 3.8K citations

Thrombosis, Hypertension, Cardiovascular Disease +12

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

Björn Dahlöf, Peter Sever, Neil R Poulter et al. · The Lancet · 2005 · 2.9K citations

Hypertension, Cardiovascular Disease, Amlodipine Adding Perindopril +11

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

Göran Walldius, Ingmar Jungner, Ingar Holme et al. · The Lancet · 2001 · 1.2K citations

Epidemiology, Cardiovascular Epidemiology, Cardiovascular Disease +12

Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol

Domenico Corrado, Antonio Pelliccia, Hans Halvor Björnstad et al. · European Heart Journal · 2005 · 1.1K citations

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)

Peter Sever, Bj rn Dahl f, Neil R Poulter et al. · Drugs · 2004 · 521 citations

Thrombosis, Hypertension, Health Policy +14